The neurotransmitter dopamine modulates vascular permeability in the endothelium
Open Access
- 28 July 2008
- journal article
- Published by Journal of Molecular Signaling in Journal of Molecular Signaling
- Vol. 3 (1), 14
- https://doi.org/10.1186/1750-2187-3-14
Abstract
Vascular permeability factor/Vascular endothelial growth factor (VPF/VEGF), a multifunctional cytokine, is a potent inducer of vascular permeability, an important early step in angiogenesis. It is known that the neurotransmitter dopamine can inhibit VPF/VEGF mediated angiogenesis, in particular microvascular permeability, but the effectors of this action remain unclear. Here, we define the signaling pathway modulated by dopamine that inhibits VPF/VEGF induced vascular permeability in endothelial cells. Signals from VPF/VEGF lead to changes in the phosphorylation of tight junction protein zonula occludens (ZO-1) and adherens junction proteins like VE-cadherin and associated catenins, thus weakening endothelial cell-cell adhesion and increasing vascular permeability. We found VEGF receptor-2 (VEGFR-2) to be part of a multi-protein complex involving ZO-1, VE-cadherin and β-catenin. VPF/VEGF induced phosphorylations of VE-cadherin, β-catenin and ZO-1 were inhibited by dopamine treatment. Association of occludin with ZO-1 and ZO-1 with VE-cadherin were significantly inhibited by dopamine in VEGF treated cells. Furthermore, we identified Src as an important target for dopamine-mediated inhibition of VPF/VEGF induced permeability. Taken together, our results provide molecular insights of dopamine function in the vascular endothelium and suggest a central role of Src in regulating key molecules that control vascular permeability.Keywords
This publication has 36 references indexed in Scilit:
- Hypothermia-Induced Loss of Endothelial Barrier Function Is Restored after Dopamine Pretreatment: Role of p42/p44 ActivationTransplantation, 2006
- Pathophysiological consequences of VEGF-induced vascular permeabilityNature, 2005
- Regulatory role of dynamin‐2 in VEGFR‐2/KDR‐mediated endothelial signalingThe FASEB Journal, 2005
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005
- Ablation of Peripheral Dopaminergic Nerves Stimulates Malignant Tumor Growth by Inducing Vascular Permeability Factor/Vascular Endothelial Growth Factor-Mediated AngiogenesisCancer Research, 2004
- Depleted Dopamine in Gastric Cancer TissuesClinical Cancer Research, 2004
- VEGF and the quest for tumour angiogenesis factorsNature Reviews Cancer, 2002
- Thrombin-Induced Increase in Endothelial Permeability Is Associated With Changes in Cell-to-Cell Junction OrganizationArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Cell Adhesion: The Molecular Basis of Tissue Architecture and MorphogenesisCell, 1996
- Occludin: a novel integral membrane protein localizing at tight junctions.The Journal of cell biology, 1993